Northeast Cannabis Operators Eye Relief as Treasury Promises Tax Guidance After Rescheduling Move

For the owners of licensed cannabis dispensaries from Providence to Philadelphia, one number has haunted their books longer than any other: 280E. That’s the section of the federal tax code that bars cannabis businesses — even fully state-licensed ones — from deducting ordinary business expenses, because the IRS still classifies marijuana as a Schedule I controlled substance. It’s a provision that can effectively tax legitimate operators at rates of 60 to 80 percent of gross profit, making survival in an already crowded and price-compressed market feel like a war of attrition.

Now, that may finally be changing.

In a joint press release, the Treasury Department and the IRS announced that they “expect DOJ’s action to have significant positive tax consequences for businesses in the medical marijuana industry,” signaling that formal guidance is forthcoming. The statement follows the recent federal move toward rescheduling cannabis — a shift that, if codified through tax policy, would allow state-licensed cannabis businesses to finally deduct the kinds of costs that every other American business takes for granted: rent, payroll, utilities, cost of goods sold.

For the Northeast’s legal cannabis market, the timing matters enormously.

A Tax Code That Punishes the Legal Market

To understand why this announcement landed with such weight, you have to understand what 280E has actually cost Northeast operators.

In New York — where the adult-use rollout has been one of the most scrutinized in the country — licensed dispensaries have been competing in a market still flooded with unlicensed smoke shops. One of the central reasons legacy operators have struggled to compete on price is that legal shops carry a federal tax burden their illicit competitors simply don’t pay. The same dynamic plays out in New Jersey, where a rush of dispensary openings has created intense price competition, and in Massachusetts, where the legal market is more mature but operators have been dealing with thinner margins every year.

Pennsylvania, still operating under a medical-only framework, faces its own version of the problem. Medical cannabis businesses there have watched their compliance and operational costs balloon while 280E silently erases the financial runway needed to expand, hire, or lower prices for patients.

The cruel irony has never been lost on anyone in the industry: the more a business tries to operate professionally — paying employees on the books, leasing proper retail space, investing in compliance infrastructure — the harder the tax hit under 280E. Underground operations feel none of it.

What the Treasury Signal Actually Means

The joint Treasury-IRS statement stopped short of issuing guidance itself. What it did was acknowledge that the DOJ’s recent actions on cannabis scheduling are expected to “have significant positive tax consequences” for licensed medical operators — and that direction is coming.

That’s meaningful, but it’s not a done deal. Tax practitioners who work with cannabis businesses have noted for years that the link between DEA scheduling and 280E applicability is not automatic. Congressional action may ultimately be required to fully sever cannabis from 280E’s reach, particularly for adult-use businesses. The Treasury statement specifically referenced medical marijuana, which leaves adult-use operators in states like New York, New Jersey, Massachusetts, and Connecticut in a murkier position.

Still, any formal guidance from the IRS — even if it only covers medical-licensed operators initially — would represent the first concrete federal tax relief the industry has ever received. And for operators in the Northeast, where state licensing fees, municipal costs, and compliance overhead are among the highest in the country, that relief could be the difference between staying open and folding.

The Broader Federal Shift

The Treasury announcement didn’t arrive in isolation. Around the same time, President Trump publicly called on Congress to loosen federal restrictions on hemp-derived CBD and other cannabinoids, citing the difference they’ve made for Americans. “Hemp-derived CBD has made a HUGE difference for so many people,” Trump posted on social media. While the CBD push and the 280E guidance are separate policy tracks, together they represent the most active federal engagement with cannabis-adjacent commerce in years.

For Northeast cannabis advocates, the political optics are notable. The region has historically led on state-level cannabis reform while watching federal intransigence block full normalization. The fact that movement on both tax policy and hemp regulation is coming from a Republican administration — rather than through the more expected legislative pathway — is a realignment worth watching.

What Operators Are Hoping For

Across the Northeast, the ask from licensed operators has been consistent for years: let us deduct what every other small business deducts. Let us pay our employees on the books without it becoming a tax liability. Let us invest in our stores, our safety infrastructure, our communities — without the federal government taxing us into the red for doing so.

The Treasury guidance, when it arrives, will be dissected carefully. Questions will center on which business classifications qualify, how the guidance interacts with state-specific licensing structures (New York’s CAURD licensees, New Jersey’s original ATC operators, Pennsylvania’s grower-processors all have different legal footprints), and whether adult-use operators are included from the start or left to fight that battle separately.

In the meantime, cannabis business attorneys and CPAs throughout the region are likely already reviewing client portfolios — identifying which operators stand to benefit most, which structures may need adjustment, and how to position for whatever the IRS ultimately puts in writing.

The Northeast built some of the most regulated, most taxed, and most scrutinized cannabis markets in the country. The operators who survived this far didn’t do it by cutting corners. If Washington finally follows through on tax relief, it won’t be charity — it’ll be a correction long overdue.

Dana Reeves covers Northeast cannabis markets for CannabisInquirer.com.